LATEST
GTCR agreed to acquire CCC Intelligent SolutionsEQT agreed to acquire StockbridgeProofpoint agreed to acquire VaronisPyrophyte Acquisition . II / SakuuMotown Acquisition agreed to acquire Penske Automotive GroupVivos Therapeutics / SOD SciencesAtlasClear Holdings agreed to acquire Ark Financial ServicesLaboratory of America Holdings / BioReference HealthMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire Rocscience
Open App
ClosedPublished 4 Mar 2026

Azenta, Inc. /
UK Biocentre Limited

Azenta, Inc. buys UK Biocentre Limited to build out its biorepository business in Europe

Buy side: Azenta, Inc.
Buy sideAzenta, Inc.
Target: UK Biocentre Limited
TargetUK Biocentre Limited
Azenta, Inc. · 4 Mar 2026Source
See the source
Buy side: Azenta, Inc.
Buy sideAzenta, Inc.
Target: UK Biocentre Limited
TargetUK Biocentre Limited
01 / BuyerAzenta, Inc.
02 / TargetUK Biocentre Limited
Source for the buyer and target: Azenta, Inc.

For the buyer and target.

“On March 4, 2026, Azenta UK Ltd., a wholly owned subsidiary of Azenta, Inc. (“Azenta” or the “Company”) entered into a definitive Share Purchase Agreement (“Agreement”) under which Azenta UK Ltd. acquired all the issued and outstanding share capital of UK Biocentre Limited (“UK Biocentre”), a provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom.”

Published 4 Mar 2026

Open the source
01

What happened

Azenta, Inc. has completed the purchase of UK Biocentre Limited. The deal was done on March 4, 2026 through its wholly owned subsidiary, Azenta UK Ltd. It covered all of the target's issued share capital. [01]

UK Biocentre Limited provides sample management, sample storage and high-throughput sample processing in the United Kingdom. Azenta plans to use it as a Europe-wide operations hub. The hub will work alongside Azenta's existing biorepository in Griesheim, Germany. [01]

The total consideration was GBP 20.5 million, net of cash. That figure includes up to GBP 1.8 million in contingent consideration tied to milestones. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Azenta, Inc.

Azenta, Inc. buys UK Biocentre Limited to build out its biorepository business in Europe

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Also stated

    “The deal was done on March 4, 2026 through its wholly owned subsidiary, Azenta UK Ltd. It covered all of the target's issued share capital”

    Open the source

  2. Published by Azenta, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.